SI-BONE Inc. (SIBN) PT Raised to $24 at Truist Securities Feb 24, 2026 09:37AM
SI-BONE Inc. (SIBN) PT Raised to $22 at TD Cowen Feb 24, 2026 09:22AM
Smith+Nephew partners with SI-BONE for pelvic fracture solutions Feb 23, 2026 04:31PM
SI-BONE Inc. (SIBN) Tops Q4 EPS by 8c, Beats on Revenue; Offers FY26 Revenue Guidance Feb 23, 2026 04:14PM
TD Cowen Starts SI-BONE Inc. (SIBN) at Buy Jan 26, 2026 05:30PM


Jan 12, 2026 09:02AM SI-BONE reports preliminary Q4 revenue of $56.2-56.3 million
Dec 18, 2025 02:30PM This MedTech stock was just added to Needham's Conviction List
Dec 16, 2025 07:15AM SI-BONE Inc. (SIBN) PT Raised to $27 at Needham, Added To Conviction List
Nov 11, 2025 07:25AM SI-BONE (SIBN) Reiterated at Overweight Post 3Q25 Results, Guidance Raise
Nov 11, 2025 05:56AM Needham Reiterates Buy Rating on SI-BONE Inc. (SIBN)
Nov 10, 2025 04:15PM SI-BONE Inc. (SIBN) Tops Q3 EPS by 6c, provides guidance
Aug 11, 2025 07:10AM Cantor Fitzgerald Reiterates Overweight Rating on SI-BONE Inc. (SIBN)
Aug 5, 2025 06:25AM SI-BONE Inc. (SIBN) PT Raised to $26 at Canaccord Genuity
Aug 5, 2025 05:27AM SI-BONE Inc. (SIBN) PT Raised to $28 at Jefferies
Aug 4, 2025 04:11PM SI-BONE Inc. (SIBN) Tops Q2 EPS by 4c, provides guidance
May 6, 2025 09:09AM Cantor Fitzgerald Reiterates Overweight Rating on SI-BONE Inc. (SIBN)
May 6, 2025 08:49AM Citizens JMP Reiterates Market Outperform Rating on SI-BONE Inc. (SIBN)
May 6, 2025 06:11AM Needham Reiterates Buy Rating on SI-BONE Inc. (SIBN)
May 5, 2025 04:21PM SI-BONE Inc. (SIBN) Tops Q1 EPS by 8c, provides guidance
Mar 17, 2025 07:38AM Cantor Fitzgerald newsletter says Elutia best, Anteris worst performer
Feb 25, 2025 09:28AM Cantor Fitzgerald Reiterates Overweight Rating on SI-BONE Inc. (SIBN)
Feb 25, 2025 07:14AM SI-BONE Inc. (SIBN) PT Raised to $24 at Needham
Feb 24, 2025 04:15PM SI-BONE Inc. (SIBN) Tops Q4 EPS by 4c, provides guidance
Jan 21, 2025 06:00PM MedTech sector outlook for 2025: Truist Securities
Dec 19, 2024 08:17AM Medical Technology and Devices: Piper Sandler Shares 'Quick Thoughts on HC Conference in Jan'
Dec 2, 2024 07:50AM SI-BONE Inc. (SIBN) PT Lowered to $15 at Morgan Stanley
Nov 20, 2024 06:35AM Needham Reiterates Buy Rating on SI-BONE Inc. (SIBN)
Nov 12, 2024 04:28PM SI-BONE Inc. (SIBN) Tops Q3 EPS by 8c
Oct 10, 2024 08:33AM SI-BONE Inc. (SIBN) Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation
Oct 3, 2024 07:18AM Piper Sandler Reiterates Overweight Rating on SI-BONE Inc. (SIBN)
Aug 20, 2024 12:23PM Canaccord Genuity Reiterates Buy Rating on SI-BONE Inc. (SIBN)
Aug 20, 2024 12:18PM Cantor Fitzgerald Reiterates Overweight Rating on SI-BONE Inc. (SIBN)
Aug 20, 2024 08:31AM SI-BONE Inc. (SIBN) Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System
Aug 6, 2024 07:18AM SI-BONE Inc. (SIBN) PT Lowered to $19 at Needham
Aug 5, 2024 04:25PM SI-BONE Inc. (SIBN) Tops Q2 EPS by 6c